| 摘要 |
<p>The invention provides a compound of formula (I) wherein: R1 is a group selected from: (a), (b) and (c) or a pharmaceutically acceptable salt thereof or a solvate thereof; compositions containing these compounds, processes for preparing them and their use as modulators of chemokine activity (especially CCR5 activity).</p> |
